{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:48:32Z","timestamp":1784436512927,"version":"3.55.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11635-y","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:08:06Z","timestamp":1779368886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of targeted exosomes in improving drug delivery in breast cancer: challenges and prospects"],"prefix":"10.1007","volume":"53","author":[{"given":"Mehrad Zibaei","family":"Moghadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyeh","family":"Shafieesabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"11635_CR1","doi-asserted-by":"publisher","first-page":"105049","DOI":"10.1016\/j.jddst.2023.105049","volume":"89","author":"D Nagpal","year":"2023","unstructured":"Nagpal D, Verma R, Mittal V, Jeandet P, Kaushik D (2023) Targeted therapies against breast cancer: Clinical perspectives, obstacles and new opportunities. J Drug Deliv Sci Technol 89:105049","journal-title":"J Drug Deliv Sci Technol"},{"key":"11635_CR2","doi-asserted-by":"publisher","first-page":"117327","DOI":"10.1016\/j.biopha.2024.117327","volume":"179","author":"L Gao","year":"2024","unstructured":"Gao L, Meng F, Yang Z, Lafuente-Merchan M, Fern\u00e1ndez LM, Cao Y et al (2024) Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives. Biomed Pharmacother 179:117327","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"11635_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, Fatima K, Aisha S, Malik F (2024) Unveiling the mechanisms and challenges of cancer drug resistance. Cell Communication Signal 22(1):109","journal-title":"Cell Communication Signal"},{"key":"11635_CR4","doi-asserted-by":"crossref","unstructured":"Cheng H, Liao J, Ma Y, Sarwar MT, Yang H (2025) Advances in targeted therapy for tumor with nanocarriers: A review. Mater Today Bio. 31:101583","DOI":"10.1016\/j.mtbio.2025.101583"},{"key":"11635_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","volume":"5","author":"K Elumalai","year":"2024","unstructured":"Elumalai K, Srinivasan S, Shanmugam A (2024) Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomedical Technol 5:109\u2013122","journal-title":"Biomedical Technol"},{"key":"11635_CR6","doi-asserted-by":"crossref","unstructured":"Islam S, Ahmed MMS, Islam MA, Hossain N, Chowdhury MA (2025) Advances in nanoparticles in targeted drug delivery-a review. Results Surf Interfaces. 19:100529.","DOI":"10.1016\/j.rsurfi.2025.100529"},{"key":"11635_CR7","doi-asserted-by":"crossref","unstructured":"Imtiaz S, Ferdous UT, Nizela A, Hasan A, Shakoor A, Zia AW et al (2025) Mechanistic study of cancer drug delivery: Current techniques, limitations, and future prospects. Eur J Med Chem. 290:117535.","DOI":"10.1016\/j.ejmech.2025.117535"},{"issue":"9","key":"11635_CR8","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/pharmaceutics15092233","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Wang Q, Xia G, Adilijiang N, Li Y, Hou Z et al (2023) Recent advances in targeted drug delivery strategy for enhancing oncotherapy. Pharmaceutics 15(9):2233","journal-title":"Pharmaceutics"},{"key":"11635_CR9","doi-asserted-by":"crossref","unstructured":"Goyal P, Malviya R (2023) Advances in nuclei targeted delivery of nanoparticles for the management of cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 1878(3):188881","DOI":"10.1016\/j.bbcan.2023.188881"},{"key":"11635_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","volume":"350","author":"B Sethi","year":"2022","unstructured":"Sethi B, Kumar V, Mahato K, Coulter DW, Mahato RI (2022) Recent advances in drug delivery and targeting to the brain. J Controlled Release 350:668\u2013687","journal-title":"J Controlled Release"},{"key":"11635_CR11","doi-asserted-by":"crossref","unstructured":"Su J, Yang L, Sun Z, Zhan X (2024) Personalized drug therapy: innovative concept guided with proteoformics. Mol Cell Proteom 23(3).","DOI":"10.1016\/j.mcpro.2024.100737"},{"issue":"7","key":"11635_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/cells8070727","volume":"8","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727","journal-title":"Cells"},{"key":"11635_CR13","doi-asserted-by":"crossref","unstructured":"Chen H, Li Q (2025) Recent advances in scalable exosome production: Challenges and innovations. Chin J Plast Reconstr Surg","DOI":"10.1016\/j.cjprs.2025.05.001"},{"issue":"6","key":"11635_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/biology11060804","volume":"11","author":"MA Di Bella","year":"2022","unstructured":"Di Bella MA (2022) Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine. Biology 11(6):804","journal-title":"Biology"},{"issue":"1","key":"11635_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30(1):255\u2013289","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"11635_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/membranes12050498","volume":"12","author":"S Xie","year":"2022","unstructured":"Xie S, Zhang Q, Jiang L (2022) Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes 12(5):498","journal-title":"Membranes"},{"issue":"5","key":"11635_CR17","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M, Ji J, Jin D, Wu Y, Wu T, Lin R et al (2023) The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases. Genes Dis 10(5):1894\u20131907","journal-title":"Genes Dis"},{"issue":"8","key":"11635_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/biomedicines9081061","volume":"9","author":"MI Mosquera-Heredia","year":"2021","unstructured":"Mosquera-Heredia MI, Morales LC, Vidal OM, Barcelo E, Silvera-Redondo C, V\u00e9lez JI et al (2021) Exosomes: potential disease biomarkers and new therapeutic targets. Biomedicines 9(8):1061","journal-title":"Biomedicines"},{"key":"11635_CR19","doi-asserted-by":"crossref","unstructured":"Srivastava A, Rathore S, Munshi A, Ramesh R (eds) (2022) Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment. Seminars in cancer biology. Elsevier","DOI":"10.1016\/j.semcancer.2022.02.020"},{"issue":"6","key":"11635_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41417-019-0136-4","volume":"27","author":"VP Jayaseelan","year":"2020","unstructured":"Jayaseelan VP (2020) Emerging role of exosomes as promising diagnostic tool for cancer. Cancer Gene Ther 27(6):395\u2013398","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"11635_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13205-023-03521-2","volume":"13","author":"S Sen","year":"2023","unstructured":"Sen S, Xavier J, Kumar N, Ahmad MZ, Ranjan OP (2023) Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech 13(3):101","journal-title":"3 Biotech"},{"issue":"1","key":"11635_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Feghhi M, Etemadi T (2022) A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Communication Signal 20(1):145","journal-title":"Cell Communication Signal"},{"issue":"1","key":"11635_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13287-021-02378-7","volume":"12","author":"A Hassanzadeh","year":"2021","unstructured":"Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS et al (2021) Mesenchymal stem\/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther 12(1):297","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"11635_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12935-025-03731-z","volume":"25","author":"AE Basyoni","year":"2025","unstructured":"Basyoni AE, Atta A, Salem MM, Mohamed TM (2025) Harnessing exosomes for targeted drug delivery systems to combat brain cancer. Cancer Cell Int 25(1):150","journal-title":"Cancer Cell Int"},{"key":"11635_CR25","doi-asserted-by":"crossref","unstructured":"Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z et al (2023) Engineered exosome for drug delivery: recent development and clinical applications. Int J Nanomed. 7923\u20137940","DOI":"10.2147\/IJN.S444582"},{"issue":"1","key":"11635_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","volume":"24","author":"J Li","year":"2025","unstructured":"Li J, Wang J, Chen Z (2025) Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer 24(1):13","journal-title":"Mol Cancer"},{"issue":"9","key":"11635_CR27","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2174\/1570159X21666230216095938","volume":"21","author":"Q Qu","year":"2023","unstructured":"Qu Q, Fu B, Long Y, Liu ZY, Tian XH (2023) Current Strategies for Promoting the Large-scale Production of Exosomes. Curr Neuropharmacol 21(9):1964\u20131979","journal-title":"Curr Neuropharmacol"},{"key":"11635_CR28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fphys.2018.01169","volume":"9","author":"G Andriolo","year":"2018","unstructured":"Andriolo G, Provasi E, Lo Cicero V, Brambilla A, Soncin S, Torre T et al (2018) Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method. Front Physiol 9:1169","journal-title":"Front Physiol"},{"issue":"6","key":"11635_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/1541-7786.MCR-20-0952","volume":"19","author":"T Liu","year":"2021","unstructured":"Liu T, Hooda J, Atkinson JM, Whiteside TL, Oesterreich S, Lee AV (2021) Exosomes in breast cancer\u2013mechanisms of action and clinical potential. Mol Cancer Res 19(6):935\u2013945","journal-title":"Mol Cancer Res"},{"key":"11635_CR30","doi-asserted-by":"publisher","first-page":"155214","DOI":"10.1016\/j.prp.2024.155214","volume":"255","author":"S Khoushab","year":"2024","unstructured":"Khoushab S, Aghmiuni MH, Esfandiari N, Sarvandani MRR, Rashidi M, Taheriazam A et al (2024) Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention. Pathol Res Pract 255:155214","journal-title":"Pathol Res Pract"},{"issue":"6","key":"11635_CR31","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1021\/acsbiomaterials.1c00217","volume":"7","author":"MN Huda","year":"2021","unstructured":"Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T et al (2021) Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications. ACS biomaterials Sci Eng 7(6):2106\u20132149","journal-title":"ACS biomaterials Sci Eng"},{"key":"11635_CR32","doi-asserted-by":"publisher","first-page":"115853","DOI":"10.1016\/j.biopha.2023.115853","volume":"169","author":"C Liu","year":"2023","unstructured":"Liu C, Xia C, Xia C (2023) Biology and function of exosomes in tumor immunotherapy. Biomed pharmacotherapy = Biomedecine pharmacotherapie 169:115853","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"11635_CR33","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","volume":"19","author":"M Bahadorani","year":"2024","unstructured":"Bahadorani M, Nasiri M, Dellinger K, Aravamudhan S, Zadegan R (2024) Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies. Int J Nanomed 19:7137\u20137164","journal-title":"Int J Nanomed"},{"issue":"4","key":"11635_CR34","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D (2024) Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med 56(4):836\u2013849","journal-title":"Exp Mol Med"},{"key":"11635_CR35","first-page":"100360","volume":"10","author":"L Zheng","year":"2025","unstructured":"Zheng L, Sun J, Wang L, Ding Z, Tang Y, Dai M et al (2025) Construction and applications of exosome-microneedle integrated systems. Int J pharmaceutics: X 10:100360","journal-title":"Int J pharmaceutics: X"},{"issue":"1","key":"11635_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12951-023-02081-0","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu Q, Li D, Pan X, Liang Y (2023) Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnol 21(1):334","journal-title":"J Nanobiotechnol"},{"key":"11635_CR37","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.critrevonc.2022.103628","volume":"172","author":"D Ferreira","year":"2022","unstructured":"Ferreira D, Moreira JN, Rodrigues LR (2022) New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol\/Hematol 172:103628","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"11635_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.fmre.2024.03.025","volume":"5","author":"L Li","year":"2025","unstructured":"Li L, Wang F, Zhu D, Hu S, Cheng K, Li Z (2025) Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention. Fundamental Res 5(2):851\u2013867","journal-title":"Fundamental Res"},{"key":"11635_CR39","doi-asserted-by":"publisher","first-page":"125687","DOI":"10.1016\/j.ijpharm.2025.125687","volume":"678","author":"Z Naz","year":"2025","unstructured":"Naz Z, Fareed M, Chaudhary ARH, Snigdha NT, Zafar A, Alsaidan OA et al (2025) Exploring the therapeutic potential of ligand-decorated nanostructured lipid carriers for targeted solid tumor therapy. Int J Pharm 678:125687","journal-title":"Int J Pharm"},{"issue":"1","key":"11635_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-025-02372-0","volume":"24","author":"JJJ Liu","year":"2025","unstructured":"Liu JJJ, Liu D, To SKY, Wong AST (2025) Exosomes in cancer nanomedicine: biotechnological advancements and innovations. Mol Cancer 24(1):166","journal-title":"Mol Cancer"},{"issue":"1","key":"11635_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12951-018-0388-4","volume":"16","author":"TJ Antes","year":"2018","unstructured":"Antes TJ, Middleton RC, Luther KM, Ijichi T, Peck KA, Liu WJ et al (2018) Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display. J Nanobiotechnol 16(1):61","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"11635_CR42","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J (2021) Engineering exosomes for targeted drug delivery. Theranostics 11(7):3183\u20133195","journal-title":"Theranostics"},{"key":"11635_CR43","doi-asserted-by":"publisher","first-page":"1362681","DOI":"10.3389\/fbioe.2024.1362681","volume":"12","author":"S Paul","year":"2024","unstructured":"Paul S, Bhagat S, Dash L, Mohapatra HD, Jena S, Verma SK et al (2024) ExoDS: a versatile exosome-based drug delivery platform to target cancer cells and cancer stem cells. Front Bioeng Biotechnol 12:1362681","journal-title":"Front Bioeng Biotechnol"},{"key":"11635_CR44","doi-asserted-by":"crossref","unstructured":"Zhao C, Qiu L, Wu D, Zhang M, Xia W, Lv H et al (2024) Targeted reversal of multidrug resistance in ovarian cancer cells using exosome\u2013encapsulated tetramethylpyrazine. Mol Med Rep 29(2):25.","DOI":"10.3892\/mmr.2023.13148"},{"key":"11635_CR45","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.vesic.2023.100032","volume":"3","author":"V Sharma","year":"2024","unstructured":"Sharma V, Mukhopadhyay CD (2024) Exosome as drug delivery system: Current advancements. Extracell Vesicle 3:100032","journal-title":"Extracell Vesicle"},{"key":"11635_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.reth.2025.01.019","volume":"28","author":"AK Balaraman","year":"2025","unstructured":"Balaraman AK, Arockia Babu M, Afzal M, Sanghvi G, M MR, Gupta S et al (2025) Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells. Regenerative therapy 28:558\u2013572","journal-title":"Regenerative therapy"},{"issue":"1","key":"11635_CR47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s40001-025-02618-z","volume":"30","author":"QM Hussain","year":"2025","unstructured":"Hussain QM, Al-Hussainy AF, Sanghvi G, Roopashree R, Kashyap A, Anand DA et al (2025) Dual role of miR-155 and exosomal miR-155 in tumor angiogenesis: implications for cancer progression and therapy. Eur J Med Res 30(1):393","journal-title":"Eur J Med Res"},{"key":"11635_CR48","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.2147\/IJN.S182384","volume":"13","author":"Z Naseri","year":"2018","unstructured":"Naseri Z, Oskuee RK, Jaafari MR, Forouzandeh Moghadam M (2018) Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int J Nanomed 13:7727\u20137747","journal-title":"Int J Nanomed"},{"issue":"17","key":"11635_CR49","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1039\/D1NR08539E","volume":"14","author":"F Zhang","year":"2022","unstructured":"Zhang F, Isak AN, Yang S, Song Y, Ren L, Feng C et al (2022) Smartly responsive DNA-miRNA hybrids packaged in exosomes for synergistic enhancement of cancer cell apoptosis. Nanoscale 14(17):6612\u20136619","journal-title":"Nanoscale"},{"key":"11635_CR50","doi-asserted-by":"publisher","first-page":"1447953","DOI":"10.3389\/fmolb.2024.1447953","volume":"11","author":"P Ubanako","year":"2024","unstructured":"Ubanako P, Mirza S, Ruff P, Penny C (2024) Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges. Front Mol Biosci 11:1447953","journal-title":"Front Mol Biosci"},{"key":"11635_CR51","doi-asserted-by":"crossref","unstructured":"Wang J, Yin B, Lian J, Wang X (2024) Extracellular Vesicles as Drug Delivery System for Cancer Therapy. Pharmaceutics 16(8)","DOI":"10.3390\/pharmaceutics16081029"},{"key":"11635_CR52","doi-asserted-by":"crossref","unstructured":"Kumar DN, Chaudhuri A, Dehari D, Shekher A, Gupta SC, Majumdar S et al (2022) Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer. Life (Basel Switzerland). 12(8):1143.","DOI":"10.3390\/life12081143"},{"key":"11635_CR53","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.1016\/j.apmt.2024.102395","volume":"40","author":"M Shao","year":"2024","unstructured":"Shao M, Rodrigues J, Sousa-Oliveira I, Moradialvand M, Asadollahi P, Veiga F et al (2024) Revolutionizing cancer treatment via bioengineered extracellular vesicles: Exploring nanovesicles to fully synthetic solutions. Appl Mater Today 40:102395","journal-title":"Appl Mater Today"},{"issue":"3","key":"11635_CR54","doi-asserted-by":"publisher","first-page":"e70095","DOI":"10.1002\/mco2.70095","volume":"6","author":"J Chen","year":"2025","unstructured":"Chen J, Hu S, Liu J, Jiang H, Wang S, Yang Z (2025) Exosomes: a double-edged sword in cancer immunotherapy. MedComm 6(3):e70095","journal-title":"MedComm"},{"key":"11635_CR55","doi-asserted-by":"publisher","first-page":"216093","DOI":"10.1016\/j.canlet.2023.216093","volume":"558","author":"R Raguraman","year":"2023","unstructured":"Raguraman R, Bhavsar D, Kim D, Ren X, Sikavitsas V, Munshi A et al (2023) Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett 558:216093","journal-title":"Cancer Lett"},{"issue":"7","key":"11635_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2217\/nnm-2022-0328","volume":"18","author":"NH Tran","year":"2023","unstructured":"Tran NH, Nguyen DD, Nguyen NM, Tran C, Nguyen Thi NT, Ho DT et al (2023) Dual-targeting exosomes for improved drug delivery in breast cancer. Nanomed (London England) 18(7):599\u2013611","journal-title":"Nanomed (London England)"},{"issue":"19","key":"11635_CR57","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1039\/D0NR00523A","volume":"12","author":"S Li","year":"2020","unstructured":"Li S, Wu Y, Ding F, Yang J, Li J, Gao X et al (2020) Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer. Nanoscale 12(19):10854\u201310862","journal-title":"Nanoscale"},{"key":"11635_CR58","doi-asserted-by":"publisher","first-page":"103584","DOI":"10.1016\/j.jddst.2022.103584","volume":"75","author":"NS De\u011firmenci","year":"2022","unstructured":"De\u011firmenci NS, Uslu M, K\u0131rba\u015f OK, \u015eahin F, \u00d6nay U\u00e7ar E (2022) Lapatinib loaded exosomes as a drug delivery system in breast cancer. J Drug Deliv Sci Technol 75:103584","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"11635_CR59","doi-asserted-by":"publisher","first-page":"200800","DOI":"10.1016\/j.omton.2024.200800","volume":"32","author":"AT Gharavi","year":"2024","unstructured":"Gharavi AT, Irian S, Niknejad A, Parang K, Salimi M (2024) Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studies. Mol therapy Oncol 32(2):200800","journal-title":"Mol therapy Oncol"},{"key":"11635_CR60","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/IJN.S355366","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, Lei B, Zhang E, Gong P, Gu J, He L et al (2022) Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. Int J Nanomed 17:1757\u20131781","journal-title":"Int J Nanomed"},{"key":"11635_CR61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","volume":"192","author":"L Pascucci","year":"2014","unstructured":"Pascucci L, Cocc\u00e8 V, Bonomi A, Ami D, Ceccarelli P, Ciusani E et al (2014) Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J controlled release: official J Controlled Release Soc 192:262\u2013270","journal-title":"J controlled release: official J Controlled Release Soc"},{"issue":"3","key":"11635_CR62","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine: Nanatechnol biology Med 12(3):655\u2013664","journal-title":"Nanomedicine: Nanatechnol biology Med"},{"issue":"15","key":"11635_CR63","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.18632\/aging.102092","volume":"11","author":"L Yu","year":"2019","unstructured":"Yu L, Gui S, Liu Y, Qiu X, Zhang G, Zhang X et al (2019) Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Aging 11(15):5300\u20135318","journal-title":"Aging"},{"issue":"5","key":"11635_CR64","doi-asserted-by":"publisher","first-page":"e12669","DOI":"10.1111\/cpr.12669","volume":"52","author":"S Chen","year":"2019","unstructured":"Chen S, Tang Y, Liu Y, Zhang P, Lv L, Zhang X et al (2019) Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration. Cell Prolif 52(5):e12669","journal-title":"Cell Prolif"},{"issue":"4","key":"11635_CR65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341\u2013345","journal-title":"Nat Biotechnol"},{"issue":"10","key":"11635_CR66","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol therapy: J Am Soc Gene Therapy 19(10):1769\u20131779","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"issue":"7659","key":"11635_CR67","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA et al (2017) Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546(7659):498\u2013503","journal-title":"Nature"},{"issue":"6","key":"11635_CR68","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38(6):754\u2013763","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"11635_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.31083\/ph.2021.0128","volume":"76","author":"XM Xi","year":"2021","unstructured":"Xi XM, Xia SJ, Lu R (2021) Drug loading techniques for exosome-based drug delivery systems. Pharmazie. 76(2-3):61-7.","journal-title":"Pharmazie"},{"issue":"1","key":"11635_CR70","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z et al (2023) Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target therapy 8(1):124","journal-title":"Signal Transduct Target therapy"},{"issue":"6","key":"11635_CR71","first-page":"100870","volume":"18","author":"M Deng","year":"2023","unstructured":"Deng M, Wu S, Huang P, Liu Y, Li C, Zheng J (2023) Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence. Asian J Pharm Sci 18(6):100870","journal-title":"Asian J Pharm Sci"},{"key":"11635_CR72","doi-asserted-by":"crossref","unstructured":"Koh HB, Kim HJ, Kang SW, Yoo TH (2023) Exosome-Based Drug Delivery: Translation from Bench to Clinic. Pharmaceutics 15(8):2042.","DOI":"10.3390\/pharmaceutics15082042"},{"issue":"2","key":"11635_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ddc4020019","volume":"4","author":"T Premchandani","year":"2025","unstructured":"Premchandani T, Tatode A, Taksande J, Umekar M, Qutub M, Hussain UM et al (2025) Engineered Exosomes as Smart Drug Carriers: Overcoming Biological Barriers in CNS and Cancer Therapy. Drugs Drug Candidates 4(2):19","journal-title":"Drugs Drug Candidates"},{"issue":"1","key":"11635_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cosmetics12010009","volume":"12","author":"LJ Villarreal-G\u00f3mez","year":"2025","unstructured":"Villarreal-G\u00f3mez LJ, Origel-Lucio S, Hern\u00e1ndez-Hern\u00e1ndez DA, P\u00e9rez-Gonz\u00e1lez GL (2025) Use of Exosomes for Cosmetics Applications. Cosmetics 12(1):9","journal-title":"Cosmetics"},{"issue":"1","key":"11635_CR75","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41420-025-02494-w","volume":"11","author":"G Liu","year":"2025","unstructured":"Liu G, Liu Q, Jia L, Chai Z, Jing L, Xu F et al (2025) Exosomal circRNAs: key modulators in breast cancer progression. Cell death discovery 11(1):196","journal-title":"Cell death discovery"},{"key":"11635_CR76","doi-asserted-by":"crossref","unstructured":"Rizwanullah M, Ahmad MZ, Ghoneim MM, Alshehri S, Imam SS, Md S et al (2021) Receptor-mediated targeted delivery of surface-modifiednanomedicine in breast cancer: recent update and challenges. Pharmaceutics. 13(12):2039.","DOI":"10.3390\/pharmaceutics13122039"},{"issue":"1","key":"11635_CR77","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12935-024-03514-y","volume":"24","author":"A Zabeti Touchaei","year":"2024","unstructured":"Zabeti Touchaei A, Norollahi SE, Najafizadeh A, Babaei K, Bakhshalipour E, Vahidi S et al (2024) Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy. Cancer Cell Int 24(1):334","journal-title":"Cancer Cell Int"},{"issue":"1","key":"11635_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","volume":"21","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T (2022) Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer 21(1):179","journal-title":"Mol Cancer"},{"issue":"1","key":"11635_CR79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","volume":"21","author":"S Ohno","year":"2013","unstructured":"Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N et al (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol therapy: J Am Soc Gene Therapy 21(1):185\u2013191","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"key":"11635_CR80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bioactmat.2021.08.029","volume":"10","author":"A Thakur","year":"2022","unstructured":"Thakur A, Parra DC, Motallebnejad P, Brocchi M, Chen HJ (2022) Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics. Bioactive Mater 10:281\u2013294","journal-title":"Bioactive Mater"},{"issue":"7578","key":"11635_CR81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329\u2013335","journal-title":"Nature"},{"issue":"1","key":"11635_CR82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-025-03689-y","volume":"25","author":"FA Attar","year":"2025","unstructured":"Attar FA, Irani S, Oloomi M, Bolhassani A, Geranpayeh L, Atyabi F (2025) Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study. Cancer Cell Int 25(1):72","journal-title":"Cancer Cell Int"},{"key":"11635_CR83","doi-asserted-by":"crossref","unstructured":"Bhatia R, Chang J, Munoz JL, Walker ND (2023) Forging new therapeutic targets: efforts of tumor derived exosomes to prepare the pre-metastatic niche for cancer cell dissemination and dormancy. Biomedicines. 11(6):1614.","DOI":"10.3390\/biomedicines11061614"},{"key":"11635_CR84","doi-asserted-by":"crossref","unstructured":"Sergazy S, Seydahmetova R, Gulyayev A, Shulgau Z, Aljofan M (2025) The role of exosomes in cancer progression and therapy. Biology (Basel). 14(1):27.","DOI":"10.3390\/biology14010027"},{"issue":"1","key":"11635_CR85","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00432-024-06066-w","volume":"151","author":"T Zemanek","year":"2024","unstructured":"Zemanek T, Danisovic L, Nicodemou A (2024) Exosomes, their sources, and possible uses in cancer therapy in the era of personalized medicine. J Cancer Res Clin Oncol 151(1):16","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"11635_CR86","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1002\/wnan.1835","volume":"15","author":"KP De Sousa","year":"2023","unstructured":"De Sousa KP, Rossi I, Abdullahi M, Ramirez MI, Stratton D, Inal JM (2023) Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy. Wiley interdisciplinary reviews Nanomed Nanobiotechnol 15(1):e1835","journal-title":"Wiley interdisciplinary reviews Nanomed Nanobiotechnol"},{"issue":"6","key":"11635_CR87","doi-asserted-by":"publisher","first-page":"e70040","DOI":"10.1002\/wnan.70040","volume":"17","author":"Z Naz","year":"2025","unstructured":"Naz Z, Fareed M, Snigdha NT, Zafar A, Alsaidan OA, Aslam M et al (2025) Harnessing the Power of D-Alpha-Tocopheryl Polyethylene Glycol Succinate-Based Nanoparticles for Targeted Breast Cancer Therapy. Wiley interdisciplinary reviews Nanomed Nanobiotechnol 17(6):e70040","journal-title":"Wiley interdisciplinary reviews Nanomed Nanobiotechnol"},{"issue":"1","key":"11635_CR88","first-page":"53","volume":"17","author":"J Kim","year":"2022","unstructured":"Kim J, Li S, Zhang S, Wang J (2022) Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J Pharm Sci 17(1):53\u201369","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"11635_CR89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell communication signaling: CCS 19(1):47","journal-title":"Cell communication signaling: CCS"},{"issue":"23","key":"11635_CR90","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/D4NA00501E","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S et al (2024) A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv 6(23):5803\u20135826","journal-title":"Nanoscale Adv"},{"issue":"15","key":"11635_CR91","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.7150\/thno.74305","volume":"12","author":"Y Jia","year":"2022","unstructured":"Jia Y, Yu L, Ma T, Xu W, Qian H, Sun Y et al (2022) Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications. Theranostics 12(15):6548\u20136575","journal-title":"Theranostics"},{"key":"11635_CR92","doi-asserted-by":"crossref","unstructured":"Serrano DR, Juste F, Anaya BJ, Ramirez BI, S\u00e1nchez-Guirales SA, Quispillo JM et al (2025) Exosome-based drug delivery: a next-generation platform for cancer, infection, neurological and immunological diseases, gene therapy and regenerative medicine. Pharmaceutics. 17(10):1336.","DOI":"10.3390\/pharmaceutics17101336"},{"issue":"1","key":"11635_CR93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12964-025-02268-y","volume":"23","author":"SG Gabaran","year":"2025","unstructured":"Gabaran SG, Ghasemzadeh N, Rahnama M, Karatas E, Akbari A, Rezaie J (2025) Functionalized exosomes for targeted therapy in cancer and regenerative medicine: genetic, chemical, and physical modifications. Cell communication signaling: CCS 23(1):265","journal-title":"Cell communication signaling: CCS"},{"issue":"4","key":"11635_CR94","doi-asserted-by":"publisher","first-page":"155932581989100","DOI":"10.1177\/1559325819891004","volume":"17","author":"C Ma","year":"2019","unstructured":"Ma C, Jiang F, Ma Y, Wang J, Li H, Zhang J (2019) Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic. Dose-response: publication Int Hormesis Soc 17(4):1559325819891004","journal-title":"Dose-response: publication Int Hormesis Soc"},{"issue":"7","key":"11635_CR95","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00216-022-04362-3","volume":"415","author":"M Havers","year":"2023","unstructured":"Havers M, Broman A, Lenshof A, Laurell T (2023) Advancement and obstacles in microfluidics-based isolation of extracellular vesicles. Anal Bioanal Chem 415(7):1265\u20131285","journal-title":"Anal Bioanal Chem"},{"issue":"51","key":"11635_CR96","first-page":"e2002440","volume":"32","author":"GH Nam","year":"2020","unstructured":"Nam GH, Choi Y, Kim GB, Kim S, Kim SA, Kim IS (2020) Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy. Advanced materials (Deerfield Beach. Fla) 32(51):e2002440","journal-title":"Fla)"},{"key":"11635_CR97","doi-asserted-by":"crossref","unstructured":"Lorite P, Dom\u00ednguez JN, Palomeque T, Torres MI (2024) Extracellular Vesicles: Advanced Tools for Disease Diagnosis, Monitoring, and Therapies. Int J Mol Sci. 26(1):189.","DOI":"10.3390\/ijms26010189"},{"issue":"8","key":"11635_CR98","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.7150\/thno.39434","volume":"10","author":"L Qiao","year":"2020","unstructured":"Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A et al (2020) Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics 10(8):3474\u20133487","journal-title":"Theranostics"},{"key":"11635_CR99","doi-asserted-by":"publisher","first-page":"104579","DOI":"10.1016\/j.jddst.2023.104579","volume":"85","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Sugandhi VV, Pardeshi CV, Patil RJ, Joshi M, Patel B et al (2023) Engineered exosomes for cancer theranostics: Next-generation tumor targeting. J Drug Deliv Sci Technol 85:104579","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"11635_CR100","doi-asserted-by":"publisher","first-page":"101300","DOI":"10.1016\/j.jpha.2025.101300","volume":"15","author":"H Shen","year":"2025","unstructured":"Shen H, Li S, Lin L, Wu Q, Dong Z, Xu W (2025) Advancements in plant-derived exosome-like vesicles: Versatile bioactive carriers for targeted drug delivery systems. J Pharm Anal 15(12):101300","journal-title":"J Pharm Anal"},{"issue":"11","key":"11635_CR101","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-020-03189-z","volume":"11","author":"X Dong","year":"2020","unstructured":"Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P et al (2020) Exosomes and breast cancer drug resistance. Cell Death Dis 11(11):987","journal-title":"Cell Death Dis"},{"issue":"11","key":"11635_CR102","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/iub.2116","volume":"71","author":"H Najminejad","year":"2019","unstructured":"Najminejad H, Kalantar SM, Abdollahpour-Alitappeh M, Karimi MH, Seifalian AM, Gholipourmalekabadi M et al (2019) Emerging roles of exosomal miRNAs in breast cancer drug resistance. IUBMB Life 71(11):1672\u20131684","journal-title":"IUBMB Life"},{"key":"11635_CR103","doi-asserted-by":"crossref","unstructured":"Rana R, Devi SN, Bhardwaj AK, Yashavarddhan MH, Bohra D, Ganguly NK (2025) Exosomes as nature\u2019s nano carriers: Promising drug delivery tools and targeted therapy for glioma, vol 182. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, p 117754","DOI":"10.1016\/j.biopha.2024.117754"},{"key":"11635_CR104","doi-asserted-by":"crossref","unstructured":"Poinsot V, Pizzinat N, Ong-Meang V (2024) Engineered and mimicked extracellular nanovesicles for therapeutic delivery. Nanomaterials (Basel Switzerland). 14(7):639.","DOI":"10.3390\/nano14070639"},{"issue":"10","key":"11635_CR105","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s13346-021-01087-1","volume":"12","author":"J He","year":"2022","unstructured":"He J, Ren W, Wang W, Han W, Jiang L, Zhang D et al (2022) Exosomal targeting and its potential clinical application. Drug delivery translational Res 12(10):2385\u20132402","journal-title":"Drug delivery translational Res"},{"key":"11635_CR106","doi-asserted-by":"crossref","unstructured":"Choi H, Yim H, Park C, Ahn SH, Ahn Y, Lee A et al (2022) Targeted delivery of exosomes armed with anti-cancer therapeutics. Membr (Basel). 12(1):85.","DOI":"10.3390\/membranes12010085"},{"issue":"11","key":"11635_CR107","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1021\/acs.bioconjchem.0c00483","volume":"31","author":"C Kang","year":"2020","unstructured":"Kang C, Han P, Lee JS, Lee D, Kim D (2020) Anchor, Spacer, and Ligand-Modified Engineered Exosomes for Trackable Targeted Therapy. Bioconjug Chem 31(11):2541\u20132552","journal-title":"Bioconjug Chem"},{"issue":"1","key":"11635_CR108","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12951-024-02298-7","volume":"22","author":"Q Yang","year":"2024","unstructured":"Yang Q, Li S, Ou H, Zhang Y, Zhu G, Li S et al (2024) Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. J Nanobiotechnol 22(1):41","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"11635_CR109","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40164-025-00656-1","volume":"14","author":"J Venturini","year":"2025","unstructured":"Venturini J, Chakraborty A, Baysal MA, Tsimberidou AM (2025) Developments in nanotechnology approaches for the treatment of solid tumors. Experimental Hematol Oncol 14(1):76","journal-title":"Experimental Hematol Oncol"},{"key":"11635_CR110","doi-asserted-by":"publisher","first-page":"113129","DOI":"10.1016\/j.colsurfb.2023.113129","volume":"222","author":"MJ Carrera Espinoza","year":"2023","unstructured":"Carrera Espinoza MJ, Lin KS, Weng MT, Kunene SC, Lin YS, Liu SY (2023) Magnetic boron nitride nanosheets-based on pH-responsive smart nanocarriers for the delivery of doxorubicin for liver cancer treatment. Colloids Surf B Biointerfaces 222:113129","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"11635_CR111","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","volume":"24","author":"H Sabit","year":"2025","unstructured":"Sabit H, Pawlik TM, Radwan F, Abdel-Hakeem M, Abdel-Ghany S, Wadan AS et al (2025) Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery. Mol Cancer 24(1):160","journal-title":"Mol Cancer"},{"key":"11635_CR112","doi-asserted-by":"publisher","first-page":"1779346","DOI":"10.1155\/2022\/1779346","volume":"2022","author":"S Chen","year":"2022","unstructured":"Chen S, Sun F, Qian H, Xu W, Jiang J (2022) Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy. Stem cells Int 2022:1779346","journal-title":"Stem cells Int"},{"key":"11635_CR113","doi-asserted-by":"crossref","unstructured":"Verma N, Arora S (2025) Navigating the global regulatory landscape for exosome-based therapeutics: challenges, strategies, and future directions. Pharmaceutics. 17(8):990.","DOI":"10.3390\/pharmaceutics17080990"},{"issue":"2","key":"11635_CR114","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1061186X.2019.1641508","volume":"28","author":"Y Lin","year":"2020","unstructured":"Lin Y, Lu Y, Li X (2020) Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. J Drug Target 28(2):129\u2013141","journal-title":"J Drug Target"},{"issue":"1","key":"11635_CR115","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12935-024-03464-5","volume":"24","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Rajendran RL, Mahajan AA, Chowdhury A, Bera A, Guha S et al (2024) Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell Int 24(1):278","journal-title":"Cancer Cell Int"},{"issue":"1","key":"11635_CR116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","volume":"15","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ et al (2022) Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol 15(1):83","journal-title":"J Hematol Oncol"},{"key":"11635_CR117","doi-asserted-by":"publisher","first-page":"1093607","DOI":"10.3389\/fimmu.2022.1093607","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang S, Sun M, Cui Y, Xing J, Teng L et al (2022) Exosomes as smart drug delivery vehicles for cancer immunotherapy. Front Immunol 13:1093607","journal-title":"Front Immunol"},{"issue":"1","key":"11635_CR118","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13287-024-03783-4","volume":"15","author":"F Sani","year":"2024","unstructured":"Sani F, Shojaei S, Tabatabaei SA, Khorraminejad-Shirazi M, Latifi M, Sani M et al (2024) CAR-T cell-derived exosomes: a new perspective for cancer therapy. Stem Cell Res Ther 15(1):174","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"11635_CR119","doi-asserted-by":"publisher","first-page":"e13904","DOI":"10.1111\/cts.13904","volume":"17","author":"CK Wang","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH (2024) Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci 17(8):e13904","journal-title":"Clin Transl Sci"},{"issue":"6","key":"11635_CR120","doi-asserted-by":"publisher","first-page":"e1801268","DOI":"10.1002\/adhm.201801268","volume":"8","author":"CA Fitts","year":"2019","unstructured":"Fitts CA, Ji N, Li Y, Tan C (2019) Exploiting Exosomes in Cancer Liquid Biopsies and Drug Delivery. Adv Healthc Mater 8(6):e1801268","journal-title":"Adv Healthc Mater"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11635-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:03:51Z","timestamp":1779372231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11635-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11635"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11635-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"791"}}